WebWhat was the study population in the EORTC boost trial? stage 1-2 (T1-2, N0-1), WLE with 1 cm gross margin, ALND, 5569 pts (251 (+) margins) ... What was the chemotherapy used in the Danish 82c study? Tam: 30 daily x 1yr starting 2-4 weeks post-op. Chemo: CMF q4wk x 8 (if RT) or x 9 (no RT). WebAug 28, 2016 · Principal Findings: The primary outcome, incidence of all-cause mortality, occurred in 21.6% of the ICD group versus 23.4% of the control group (p = 0.28). Younger patients (<59 years) appeared to derive greater benefit from ICD implantation versus older patients (p for interaction = 0.009). Sudden cardiac death: 4.3% versus 8.2%; …
Postoperative radiotherapy in high-risk postmenopausal breast ... - PubMed
WebJul 2, 2024 · In this trial, 318 premenopausal women with high-risk breast cancer were randomized to mastectomy and chemotherapy or chemotherapy plus RT. Patients in the radiation arm exhibited a reduction in 10-year LRR, as in the DBCCG trials. The Danish 82c trial studied the effect of PMRT in high-risk postmenopausal women using a similar … WebThe Danish 82b and 82c trials were included node-negative patients who were eligible for this trial due to the presence of high-risk factors as invasion of pectoralis muscle or skin … greenfields care home barnstaple
Adjuvant chest wall radiotherapy for breast cancer: Black, white …
WebSep 11, 2013 · The Danish group also undertook a study in high risk postmenopausal patients. Specifically, in the Danish 82c trial randomized 1460 postmenopausal patients younger than 70 years of age after total mastectomy and axillary dissection, to postmastectomy radiation therapy in addition to tamoxifen for one year or tamoxifen alone . WebDec 5, 2024 · Apart from menopausal status, the DBCG 77B and 82C trials had identical selection criteria, but while 77B trial used classic CMF with oral cyclophosphamide a … WebMay 15, 1999 · Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Author links open overlay panel Dr Marie Overgaard MD a, Maj-Britt Jensen MSc c, Jens Overgaard MD b, Per S Hansen MD f, ... greenfields care home shropshire